FDA Recall Ongoing 2026 recordClass II
CHILDREN NYQUIL, COLD&FLU, BERRY, 8oz, 12ct
- Reason
- CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- Published
- January 21, 2026
- Distribution
- Nationwide
Data Explorer
Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.
Recall totals
All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.
36,950
Total recall recordsAll FDA and USDA recalls in Public Health Trace9,732
Class I recallsReasonable probability of serious health consequences24,263
Class II recallsTemporary or medically reversible health consequences2,873
Class III recallsNot likely to cause adverse health consequencesQuick insights
A snapshot of the most notable patterns across all recorded FDA and USDA recalls.
Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap.
53 recalls
Most common hazardLack of assurance of sterility
2,071 recalls
Download matching recalls as CSV
CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.
Filters
Metric
View
A chart of recalls grouped by month.
Download CSVSummary (Year to date)
- 1,458 recalls have been announced year to date.
- Aug 2026 was 53% lower than the previous complete period (Jul 2026: 240).
- The highest complete period was Jun 2026 (297).
- Sep 2026 is incomplete and not included in the figures above.
- Complete data
- Incomplete
A bar chart of the total number of recalls in this dataset by recall class.
| Class | Recalls |
|---|---|
| Class II | 24,263 |
| Class I | 9,732 |
| Class III | 2,873 |
| Not Yet Classified | 1 |
| Class | Recalls |
|---|---|
| Class II | 24,263 |
| Class I | 9,732 |
| Class III | 2,873 |
| Not Yet Classified | 1 |
FDA Recall Ongoing 2026 recordClass II
NYQUIL COLD & FLU -32CT/2PK
- Reason
- CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass II
LIQUID NYQUIL a) regular, 12/8oz; b) cherry, 12/8oz
- Reason
- CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass II
MOTRIN 2'S DISP.- 50CT
- Reason
- CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass II
EXCEDRIN MIGRAINE 2'S- 25 CT
- Reason
- CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass II
EXCEDRIN 2'S DISP.- 30 CT
- Reason
- CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass II
LIQUID DAYQUIL 12/8oz
- Reason
- CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass II
DAYQUIL COLD & FLU, 32CT/2PK
- Reason
- CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass II
Claritin, 20 Count, UPC: 655708016305
- Reason
- CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass II
Bayer 2Pk- 25 CT
- Reason
- CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass II
Benadryl, 25'S 2PK Box, UPC 815556020316
- Reason
- CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass II
Alka Seltzer, a) Original, 2 tablets per packet in 58 count box, UPC: 815556020033, 016500514473, b) Plus Cold & Flu, 2 tablets per packet in 36 count box, UPC: 016500594932
- Reason
- CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass II
Aleve 1's, 60 CT
- Reason
- CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass II
Advil a) Ibuprofen, Dispenser Pack, 2 tablet packets in box containing 50 individual packets, UPC: 305730154895; b) PM, Ibuprofen, Dispenser Pack, 2 Caplet packets in box containing 50 packets, UPC: 305730164559
- Reason
- CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass II
AQ 120 GFEW, Aquarion Preserved Cartridges (2) 3.7 Gallons each
- Reason
- cGMP deviations.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass II
Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
- Reason
- Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass II
TESTO-100 CIII (testosterone 100 mg), 10 Sterile Pellets per carton, Rx only, Manufactured by: Advanced Pharmaceutical Technology, 132 South Central Avenue, Elmsford, NY 10523, NDC# 57377-100-01
- Reason
- Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.
- Published
- January 21, 2026
- Distribution
- GA, NY, TX, Puerto Rico, United Kingdom,…
FDA Recall Ongoing 2026 recordClass III
Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4
- Reason
- Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall Ongoing 2026 recordClass III
Fluocinolone Acetonide Solution Topical Solution USP, 0.01%, 60-mL bottles, Rx only, Dist. by: Taro Pharmaceuticals Inc., Hawthorn, NY 10532. NDC 51672-1365-4
- Reason
- Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.
- Published
- January 21, 2026
- Distribution
- Nationwide
FDA Recall United States Terminated 2026 recordClass I
Herbs Forever
- Product
- HerbsForever- Hingwastika Churna ; Ayruvedic Herbal Suppleme…
- Reason
- Potential undeclared allergen ingredient (Wheat)
- Published
- January 21, 2026
- Distribution
- Nationwide
Data last updated:
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.
